Following a challenging period marked by both remarkable recoveries and tragic losses, Astellas is revisiting its gene therapy approach for XLMTM, offering renewed hope to affected families.
Following the sale of his company for $1.7 billion, an owner has decided to distribute $240 million among 540 dedicated employees who remained with the firm.
In a significant policy shift, a major US health provider has announced the removal of prior authorization requirements for 30% of services, a move that 93% of doctors believe is overdue.
Spanish authorities are gearing up to evacuate over 140 individuals from a cruise ship affected by hantavirus as it approaches the Canary Islands.
As the hantavirus outbreak progresses, experts express concern regarding the CDC's diminished involvement, with the WHO taking the lead in the response efforts.
In a recent discussion, Dr. Glaucomflecken highlights the necessity of maintaining local medical practices to better serve patients and communities, urging for national attention on the issue.
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
The potential dismissal of FDA Commissioner Makary could lead to another significant vacancy within RFK Jr.'s health department, raising questions about future leadership.
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
Recent findings highlight the potential of nanoparticles in fighting drug-resistant cancer, offering new hope for improving chemotherapy outcomes through advanced treatment methods.
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.
This brief outlines the GENEROUS model and explores various elements that may influence Medicaid drug costs, emphasizing the importance of confidentiality regarding certain model details.
A recent study indicates that lubiprostone, a medication typically used for constipation, may play a role in slowing the progression of chronic kidney disease in patients.
A patient who previously traveled on a cruise ship affected by a hantavirus outbreak has been hospitalized in Zurich after testing positive for the virus. Three more passengers have been evacuated.
Energy Fuels is positioning itself as a key player in the nuclear energy sector with a diverse portfolio that includes uranium, rare earth elements, and medical isotopes.
Researchers from the University of Michigan and MD Anderson Cancer Center have developed a novel nanoparticle therapy that may enhance cancer immunotherapy's safety and efficacy.
Michigan's efforts in radiation emergency preparedness showcase a proactive approach that could serve as a model for health officials nationwide.
A suspected hantavirus outbreak on a Dutch cruise ship has led to the deaths of three passengers, raising alarms about health safety on cruises.
Recent developments suggest that a political appointee may be obstructing the approval process for a Sanofi drug, raising alarms about potential political interference at the FDA.
Sanofi has requested the FDA to withdraw teplizumab from its fast-track review program following internal disagreements regarding the drug's approval.